Online citations, reference lists, and bibliographies.
← Back to Search

Biosensors For Disease Biomarker Detection

B. Battersby, Annie Chen, D. Kozak, M. Trau
Published 2012 · Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
This chapter describes the current and emerging biosensor technologies for detection of biological markers (biomarkers) associated with disease. The chapter first reviews disease biomarkers and their use, as well as the established technologies for disease biomarker detection. The chapter then discusses the issues with non~specific adsorption of proteins at surfaces and presents solutions to overcome these issues. Finally, the emerging biosensor technologies for disease biomarker detection are described.
This paper references
10.1586/14789450.4.5.617
Nanotechnology in proteomics
N. Marko (2007)
10.1126/SCIENCE.1058040
The Sequence of the Human Genome
J. Venter (2001)
10.1002/CYTO.990080616
Calibration of flow cytometric fluorescence standards using the isoparametric analysis of ligand binding.
R. C. Chatelier (1987)
10.1016/J.CCCN.2004.05.019
An ELISA-like time-resolved fluorescence immunoassay for microcystin detection.
La-mei Lei (2004)
10.1504/IJNT.2008.016920
Toward colloid-based biosensors for SNP genotyping and personalised medicine applications
A. Johnston (2008)
10.1128/AEM.66.10.4258-4265.2000
A Bead-Based Method for Multiplexed Identification and Quantitation of DNA Sequences Using Flow Cytometry
A. Spiro (2000)
10.2217/17435889.3.4.475
PSA fluoroimmunoassays using anti-PSA ScFv and quantum-dot conjugates.
Y. Wang (2008)
10.1016/0304-4165(66)90032-8
Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies
L. Wide (1966)
10.1016/0009-8981(82)90153-X
A fluorescence immunoassay for soluble antigens employing flow cytometric detection.
P. J. Lisi (1982)
10.1039/B415376F
Porous functionalised silica particles: a potential platform for biomolecular screening.
A. Johnston (2005)
10.1002/PROS.10032
Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer
K. L. Meehan (2002)
10.1016/J.BIOS.2004.06.005
Biosensing and monitoring of cell populations using the hydrogel bacterial microchip.
D. Fesenko (2005)
10.1016/S1470-2045(01)00560-5
Trends in biomarker research for cancer detection.
P. Srinivas (2001)
10.1016/J.JCIS.2007.01.092
Fluorescent organosilica micro- and nanoparticles with controllable size.
R. Vogel (2007)
10.1039/b907021d
The influence of EDTA and citrate anticoagulant addition to human plasma on information recovery from NMR-based metabolic profiling studies.
R. H. Barton (2010)
10.1016/J.BIOS.2003.08.020
Low-level detection of a Bacillus anthracis simulant using Love-wave biosensors on 36°YX LiTaO3
D. Branch (2003)
The dynamics of ligand-receptor interactions. Real-time analyses of association, dissociation, and internalization of an N-formyl peptide and its receptors on the human neutrophil.
L. Sklar (1984)
10.2144/05384SU01
Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic.
Olivia Scaros (2005)
10.1289/ehp.7843
Design of a Microsphere-Based High-Throughput Gene Expression Assay to Determine Estrogenic Potential
J. Naciff (2005)
10.1007/BF03260049
Proteomic patterns as a diagnostic tool for early-stage cancer
T. Conrads (2012)
10.1002/cyto.a.20534
Quantitative data analysis methods for bead‐based DNA hybridization assays using generic flow cytometry platforms
S. Corrie (2008)
10.1039/B200038P
Optical barcoding of colloidal suspensions: applications in genomics, proteomics and drug discovery.
B. Battersby (2002)
10.1016/S0167-7799(01)01910-2
Protein microarray technology.
D. Stoll (2002)
10.1021/LA026327Q
Covalent Coupling of Antibodies to Self-Assembled Monolayers of Carboxy-Functionalized Poly(ethylene glycol): Protein Resistance and Specific Binding of Biomolecules†
S. Herrwerth (2003)
10.1071/CH07006
Optically Encoded Particles and Their Applications in Multiplexed Biomedical Assays
B. Battersby (2007)
10.1016/S0167-7799(01)01844-3
Suspension array technology: evolution of the flat-array paradigm.
J. P. Nolan (2002)
Biosensing cancer biomarkers
M. Trau (2009)
10.1093/BFGP/2.2.147
Proteomic profiling of cancer biomarkers.
H. Shau (2003)
10.2144/03345RR01
Hydrogel-based protein microchips: manufacturing, properties, and applications.
A. Rubina (2003)
10.7150/IJBS.3.108
Application of Nanotechnology in Cancer Research: Review of Progress in the National Cancer Institute's Alliance for Nanotechnology
B. Ehdaie (2007)
10.1586/14737159.3.5.525
Biomarkers: current perspectives and future prospects
S. Naylor (2003)
10.1186/1746-1596-1-1
Introducing Diagnostic Pathology
K. Kayser (2006)
10.1043/1543-2165(2008)132[384:AOITTD]2.0.CO;2
Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung.
J. Jagirdar (2008)
10.3181/00379727-47-13084P
Immunological Properties of an Antibody Containing a Fluorescent Group.∗
A. H. Coons (1941)
10.1039/b817080k
Modification and optimization of organosilica microspheres for peptide synthesis and microsphere-based immunoassays.
Peter P T Surawski (2009)
Acoustic wave sensors : theory, design, and physico-chemical applications
D. S. Ballantine (1997)
10.1016/S0022-5347(17)38491-4
Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
J. Oesterling (1991)
10.1309/KM95-6LVL-UNLB-R3RH
Standardization of clinical immunohistochemistry: why, how, and by whom?
C. Moskaluk (2002)
10.1038/nrc1043
Early detection: Proteomic applications for the early detection of cancer
J. Wulfkuhle (2003)
10.1039/b909087h
'On-the-fly' optical encoding of combinatorial peptide libraries for profiling of protease specificity.
Lionel Marcon (2010)
10.1080/08927010802058471
Particle-by-particle quantification of protein adsorption onto poly(ethylene glycol) grafted surfaces
A. Chen (2008)
10.1016/j.ab.2008.01.034
A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteases.
Lionel Marcon (2008)
Dekker Encyclopedia of Nanoscience and Nanotechnology
C. Contescu (2004)
10.1039/B509503D
Biomolecular screening with novel organosilica microspheres.
C. R. Miller (2005)
10.1016/S0022-1759(98)00112-4
Use of an albumin-binding domain for the selective immobilisation of recombinant capture antibody fragments on ELISA plates.
T. Koenig (1998)
10.1016/S0169-4332(02)01220-5
Ultrathin poly(ethylene glycol) films for silicon-based microdevices
S. Sharma (2003)
10.1038/nbt1138
Multiplexed electrical detection of cancer markers with nanowire sensor arrays
G. Zheng (2005)
10.1586/erm.09.47
Microelectrical sensors as emerging platforms for protein biomarker detection in point-of-care diagnostics
David L Arruda (2009)
10.2217/17520363.1.2.293
Challenges in developing DNA and RNA biomarkers of inflammation.
P. Dedon (2007)
10.1136/bmj.322.7297.1285
Point of care testing
C. Price (2001)
10.1354/vp.42-4-405
Technical Aspects of Immunohistochemistry
J. Ramos-Vara (2005)
10.1039/B714309E
A structural study of hybrid organosilica materials for colloid-based DNA biosensors
S. Corrie (2008)
10.1016/J.CCA.2006.02.045
A selected history and future of immunoassay development and applications in clinical chemistry.
A. Wu (2006)
10.1016/J.JIM.2005.04.007
A comparability study of the emerging protein array platforms with established ELISA procedures.
S. Pang (2005)
10.1016/J.CLIM.2003.11.017
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology.
E. Morgan (2004)
10.1021/MA00206A035
Static and dynamic properties of poly(ethylene oxide) in methanol
P. Zhou (1990)
10.1016/S0304-3886(03)00062-7
Selective detection of specific bacteria using dielectrophoretic impedance measurement method combined with an antigen-antibody reaction
J. Suehiro (2003)
10.1038/ng1037
Protein microarrays and proteomics
G. MacBeath (2002)
10.1073/pnas.0810822105
Multiplex protein assays based on real-time magnetic nanotag sensing
S. Osterfeld (2008)
10.1016/J.BIOS.2006.09.032
A Love wave immunosensor for whole E. coli bacteria detection using an innovative two-step immobilisation approach.
N. Moll (2007)
10.1016/J.EURPOLYMJ.2005.06.010
Bioartificial materials based on blends of dextran and poly(vinyl alcohol-co-acrylic acid)
N. Barbani (2005)
10.1016/j.cell.2007.07.032
Is Proteomics the New Genomics?
J. Cox (2007)
10.1002/CYTO.990020405
Three-color fluorescence measurements on single cells excited at three laser wavelengths.
J. Steinkamp (1982)
10.1006/JCIS.1994.1182
Structural and electrostatic properties of globular proteins at a polystyrene-water interface
C. Haynes (1994)
10.1007/BF02854909
Monoclonal antibody form and function: Manufacturing the right antibodies for treating drug abuse
E. Peterson (2008)
10.1108/02602280510620088
Nanoparticle‐based assay set to revolutionise clinical diagnostics
Robert Bogue (2005)
10.1021/ac801394d
Labeless immunosensor assay for the stroke marker protein neuron specific enolase based upon an alternating current impedance protocol.
Andrew C. Barton (2008)
10.1021/LA0602766
High salt stability and protein resistance of poly(L-lysine)-g-poly(ethylene glycol) copolymers covalently immobilized via aldehyde plasma polymer interlayers on inorganic and polymeric substrates.
T. Blättler (2006)
10.1021/LA034057L
Nanoscale Intermolecular Interactions between Human Serum Albumin and Low Grafting Density Surfaces of Poly(ethylene oxide)
Monica A. Rixman (2003)
10.1109/IEMBS.2006.260742
Fabrication of impedimetric sensors for label-free Point-of-Care immunoassay cardiac marker systems, with passive microfluidic delivery
M. Tweedie (2006)
10.1016/j.mad.2006.11.021
Protein microarray technology
D. A. Hall (2007)
10.1093/BFGP/4.1.69
Proteomics approaches to biomarker detection.
Ming Zhou (2005)
10.1038/nrc1739
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
J. Ludwig (2005)
10.1021/CM0526260
A Mechanism for Forming Large Fluorescent Organo-Silica Particles: Potential Supports for Combinatorial Synthesis
A. Johnston (2006)
10.1136/pgmj.2008.073759
How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
V. Puntmann (2009)
10.1021/ac7024199
Development of a high-affinity anti-domoic acid sheep scFv and its use in detection of the toxin in shellfish.
Iain Shaw (2008)
10.1016/0019-2791(71)90454-X
Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.
E. Engvall (1971)
10.1016/S0142-9612(01)00334-9
Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins.
P. Kingshott (2002)
10.1093/clinchem/43.9.1749
Advanced multiplexed analysis with the FlowMetrix system.
R. J. Fulton (1997)
10.1016/S0167-7012(03)00028-9
Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMAP system.
S. Dunbar (2003)
10.1002/cncr.20480
Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
J. Hernández (2004)
10.1002/smll.200801887
Synthesis and application of FRET nanoparticles in the profiling of a protease.
Lionel Marcon (2009)
10.1016/S0301-472X(02)00922-0
Multiplexed microsphere-based flow cytometric assays.
K. Kellar (2002)
10.1364/AO.42.000526
Flow cytometric determination of size and complex refractive index for marine particles: comparison with independent and bulk estimates.
R. E. Green (2003)
10.1016/J.MSEC.2008.04.010
Applications of polymers for biomolecule immobilization in electrochemical biosensors
F. Teles (2008)
10.1002/cyto.a.20266
Multiplexed and microparticle‐based analyses: Quantitative tools for the large‐scale analysis of biological systems
J. Nolan (2006)
10.1016/S0022-1759(00)00238-6
Multiplexed particle-based flow cytometric assays.
D. Vignali (2000)
10.1021/AC069419J
Nanowire-based biosensors.
Fernando Patolsky (2006)
10.1021/PR0703223
A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
L. Gortzak-Uzan (2008)
10.1016/S0749-0690(05)70075-6
New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future.
D. Galasko (2001)
10.1038/sj.gt.3300685
Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins
H. Whittington (1998)
10.1002/9783527609956
The SQUID handbook
J. Clarke (2006)
10.1002/PMIC.200300600
Protein microarrays: Promising tools for proteomic research
M. Templin (2003)
10.1002/jps.21350
PEGylation as a tool for the biomedical engineering of surface modified microparticles.
Uta Wattendorf (2008)
10.1021/JP050431+
Effects of ionic strength and surface charge on protein adsorption at PEGylated surfaces.
S. Pasche (2005)
10.1109/MEMB.2003.1237526
Microsphere suspension array technology for SNP detection in cattle
S. Dunbar (2003)
10.1002/1615-9861(200110)1:10<1249::AID-PROT1249>3.0.CO;2-1
Hepatocellular carcinoma: From bedside to proteomics
T. K. Seow (2001)
10.1039/b718513h
Flow cytometric detection of proteolysis in peptide libraries synthesised on optically encoded supports.
Peter P T Surawski (2008)
10.1093/clinchem/46.9.1498
Application of the luminex LabMAP in rapid screening for mutations in the cystic fibrosis transmembrane conductance regulator gene: A pilot study
Dunbar (2000)
10.1038/nnano.2009.353
Label-free biomarker detection from whole blood
E. Stern (2010)
10.1258/000456303321016141
Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases
M. Verbeek (2003)
10.1081/MA-120006522
THE EFFECT OF CHAIN LENGTH OF POLYETHYLENE GLYCOL ON PROPERTIES OF CASTOR OIL BASED POLYURETHANE ELASTOMERS
V. Bharadwaj (2002)
10.1016/S0168-1656(98)00094-7
Expression of a fusion protein of scFv-biotin mimetic peptide for immunoassay.
D. Luo (1998)
10.1002/1522-2683(20000601)21:11<2115::AID-ELPS2115>3.0.CO;2-K
Bladder squamous cell carcinoma biomarkers derived from proteomics
Julio E. Celis (2000)
10.1088/1742-6596/100/5/052044
Interdigitated microelectrode based impedance biosensor for detection of salmonella enteritidis in food samples
G. Kim (2008)
10.1038/nrc1566
Cancer nanotechnology: opportunities and challenges
M. Ferrari (2005)
10.1002/ANIE.200501264
Nanoparticle assemblies with molecular springs: a nanoscale thermometer.
Jaebeom Lee (2005)
10.1006/JCIS.1998.5513
Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings
M. Malmsten (1998)
10.1038/nature06916
Mining the plasma proteome for cancer biomarkers
S. Hanash (2008)
10.1043/1543-2165(2008)132[323:ITAN]2.0.CO;2
Immunohistochemistry: then and now.
J. Jagirdar (2008)
10.1248/CPB.51.815
Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes.
K. Hashizaki (2003)
10.1021/ac071382v
Biologically produced bifunctional recombinant protein nanoparticles for immunoassays.
A. Jääskeläinen (2008)
10.1038/nbt0806-905
Cancer biomarkers: a systems approach
L. Hartwell (2006)
Poly(Ethylene Glycol) Chemistry Biotechnical and Biomedical Applications
J. M. Harris (1992)
10.1021/ac7018624
Engineering peptide linkers for scFv immunosensors.
Zhihong Shen (2008)
10.1021/LA050386X
Relationship between interfacial forces measured by colloid-probe atomic force microscopy and protein resistance of poly(ethylene glycol)-grafted poly(L-lysine) adlayers on niobia surfaces.
S. Pasche (2005)
10.1021/la903148n
Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.
A. Chen (2009)
10.1039/B517148B
An impedance array biosensor for detection of multiple antibody-antigen interactions.
X. Yu (2006)
10.1602/neurorx.1.2.182
Biomarkers: Potential uses and limitations
R. Mayeux (2011)
10.1007/BF02664935
Proteomic analysis in cancer research: potential application in clinical use
J. García-Foncillas (2006)
10.1021/MA971016L
Poly(ethylene oxide) Grafted to Silicon Surfaces: Grafting Density and Protein Adsorption.
Sofía (1998)
10.1016/J.CANLET.2007.04.012
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.
Lindsay A Bergan (2007)
10.1093/PROTEIN/2.8.605
Synthesis and characterization of a recombinant fragment of human alpha-fetoprotein with antigenic selectivity versus albumin.
M. M. Giuliani (1989)
10.1002/cyto.a.20293
Analysis of individual data from bead‐based assays (“bead arrays”)
James W. Jacobson (2006)
10.1021/LA701847X
Profiling protein-surface interactions of multicomponent suspensions via flow cytometry.
D. Kozak (2008)
10.1080/13102818.2008.10817531
Proteomic Techniques in Colorectal Cancer Research
D. Petrova (2008)
10.1186/1746-1596-1-11
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
S. E. Lakhan (2006)
10.1093/CLINCHEM/48.8.1178
Real-time PCR technology for cancer diagnostics.
P. Bernard (2002)
10.1039/b813077a
Development of a multiplexed bead-based assay for detection of DNA methylation in cancer-related genes.
S. Corrie (2009)
10.1016/J.JCIS.2005.01.091
BSA adsorption on bimodal PEO brushes.
W. Bosker (2005)
10.4103/0377-4929.40382
Immunohistochemistry in surgical pathology practice: a current perspective of a simple, powerful, yet complex, tool.
N. Jambhekar (2008)



Semantic Scholar Logo Some data provided by SemanticScholar